WR-S-462

WR-S-462 is a potent and selective STAT3 inhibitor with a Kd of 58 nM, blocking STAT3 phosphorylation, nuclear translocation, and downstream target gene expression. It demonstrates in vitro efficacy against TNBC cell growth and metastasis and is a valuable tool for oncology research, particularly in studying STAT3-driven cancer pathways.